Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle
Metrics: PDF 2915 views | ?
Present: Due to an error made during the manuscript revision process, a notice designating Drs. Rosanna Piccirillo and Raffaella Giavazzi as joint last authors has been omitted.
Corrected: Correct author list is provided below. Authors sincerely apologize for this oversight.
Original article: Oncotarget. 2015; 6(5): 3043-54. DOI: 10.18632/oncotarget.2812
Francesca Pretto1,4,*, Carmen Ghilardi1,*, Michele Moschetta1, Andrea Bassi2, Alessandra Rovida1, Valentina Scarlato1, Laura Talamini1, Fabio Fiordaliso3, Cinzia Bisighini3, Giovanna Damia1, Maria Rosa Bani1, Rosanna Piccirillo1,** and Raffaella Giavazzi1,**
1 Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milan, Italy
2 Department of Phisics, Politecnico di Milano, 20133 Milan, Italy3 Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milan, Italy 4 Present address: Philochem AG, 8112 Otelfingen, Switzerland
*These authors have contributed equally to this work
** Joint last authors
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.